OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in peptide drug discovery
Markus Muttenthaler, Glenn F. King, David J. Adams, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 4, pp. 309-325
Closed Access | Times Cited: 1319

Showing 1-25 of 1319 citing articles:

Therapeutic peptides: current applications and future directions
Lei Wang, Nanxi Wang, Wenping Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1155

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 405

Cyclic Peptides for Drug Development
Xinjian Ji, Alexander L. Nielsen, Christian Heinis
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 141

Macrocyclization strategies for cyclic peptides and peptidomimetics
Clément Bechtler, Christina Lamers
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 8, pp. 1325-1351
Open Access | Times Cited: 140

Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences
Junjie Huang, Yanchao Xu, Yunfan Xue, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 6, pp. 797-810
Closed Access | Times Cited: 134

Sustainability in peptide chemistry: current synthesis and purification technologies and future challenges
Lucia Ferrazzano, Martina Catani, Alberto Cavazzini, et al.
Green Chemistry (2022) Vol. 24, Iss. 3, pp. 975-1020
Open Access | Times Cited: 133

Strategies for Improving Peptide Stability and Delivery
Othman Al Musaimi, Lucia Lombardi, Daryl R. Williams, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1283-1283
Open Access | Times Cited: 107

ToxIBTL: prediction of peptide toxicity based on information bottleneck and transfer learning
Lesong Wei, Xiucai Ye, Tetsuya Sakurai, et al.
Bioinformatics (2022) Vol. 38, Iss. 6, pp. 1514-1524
Open Access | Times Cited: 102

Accurate de novo design of membrane-traversing macrocycles
Gaurav Bhardwaj, Jacob O’Connor, Stephen Rettie, et al.
Cell (2022) Vol. 185, Iss. 19, pp. 3520-3532.e26
Open Access | Times Cited: 101

Alternative therapeutic strategies to treat antibiotic-resistant pathogens
Craig R. MacNair, Steven T. Rutherford, Man‐Wah Tan
Nature Reviews Microbiology (2023) Vol. 22, Iss. 5, pp. 262-275
Closed Access | Times Cited: 88

Evolutionary origins and interactomes of human, young microproteins and small peptides translated from short open reading frames
Clara-Louisa Sandmann, Jana Felicitas Schulz, Jorge Ruiz‐Orera, et al.
Molecular Cell (2023) Vol. 83, Iss. 6, pp. 994-1011.e18
Open Access | Times Cited: 85

Molecularly Stimuli-Responsive Self-Assembled Peptide Nanoparticles for Targeted Imaging and Therapy
Yang Zhou, Qianqian Li, Ye Wu, et al.
ACS Nano (2023) Vol. 17, Iss. 9, pp. 8004-8025
Closed Access | Times Cited: 83

Liquid-Phase Peptide Synthesis (LPPS): A Third Wave for the Preparation of Peptides
Anamika Sharma, Ashish Kumar, Beatriz G. de la Torre, et al.
Chemical Reviews (2022) Vol. 122, Iss. 16, pp. 13516-13546
Open Access | Times Cited: 82

Design of target specific peptide inhibitors using generative deep learning and molecular dynamics simulations
Sijie Chen, Tong Lin, Ruchira Basu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 80

Advancements, challenges and future perspectives on peptide-based drugs: Focus on antimicrobial peptides
Xiaofang Luo, Huifang Chen, Yannan Song, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 181, pp. 106363-106363
Closed Access | Times Cited: 77

Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
Giacomo Rossino, Emanuela Marchese, Giovanni Galli, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7165-7165
Open Access | Times Cited: 77

Enantioselective Deaminative Alkylation of Amino Acid Derivatives with Unactivated Olefins
Shang‐Zheng Sun, Yueming Cai, Deliang Zhang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 3, pp. 1130-1137
Closed Access | Times Cited: 76

Beyond 20 in the 21st Century: Prospects and Challenges of Non-canonical Amino Acids in Peptide Drug Discovery
Jennifer L. Hickey, Dan Sindhikara, Susan L. Zultanski, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 557-565
Open Access | Times Cited: 75

Single-Molecule Junction: A Reliable Platform for Monitoring Molecular Physical and Chemical Processes
Xinmiao Xie, Peihui Li, Yanxia Xu, et al.
ACS Nano (2022) Vol. 16, Iss. 3, pp. 3476-3505
Closed Access | Times Cited: 73

Derivatization with fatty acids in peptide and protein drug discovery
Peter Kurtzhals, Søren Østergaard, Erica Nishimura, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 59-80
Closed Access | Times Cited: 72

Advances in the stability challenges of bioactive peptides and improvement strategies
Jingyan Pei, Xinchang Gao, Daodong Pan, et al.
Current Research in Food Science (2022) Vol. 5, pp. 2162-2170
Open Access | Times Cited: 70

Deep generative models for peptide design
Fangping Wan, Daphne Kontogiorgos-Heintz, César de la Fuente‐Núñez
Digital Discovery (2022) Vol. 1, Iss. 3, pp. 195-208
Open Access | Times Cited: 69

GreenMedChem: the challenge in the next decade toward eco-friendly compounds and processes in drug design
Carola Castiello, Pierre Junghanns, Annika M. Mergel, et al.
Green Chemistry (2023) Vol. 25, Iss. 6, pp. 2109-2169
Open Access | Times Cited: 63

Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics
Panchali Barman, Shubhi Joshi, Sheetal Sharma, et al.
International Journal of Peptide Research and Therapeutics (2023) Vol. 29, Iss. 4
Open Access | Times Cited: 63

Peptidomics
Roland Hellinger, Arnar Sigurdsson, Wenxin Wu, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 56

Page 1 - Next Page

Scroll to top